Literature DB >> 31324704

Hyperammonemic Encephalopathy due to Ureaplasma parvum Infection in an Immunocompromised Child.

Mallory Smith1, Jonathan D Crews1, Nadia Cheek, Rachana Srivastava, Elumalai Appachi.   

Abstract

Idiopathic hyperammonemia is a rare complication with a high mortality rate that occurs in persons with hematologic malignancies or hematopoietic stem cell or solid organ transplant. Patients present with encephalopathy and hyperammonemia in the absence of liver disease or inborn errors of metabolism. Several etiologies have been proposed, including chemotherapeutic agents, medications, and a catabolic state with an elevated nitrogen load in the setting of acute illness. Recently, cases of hyperammonemia in adult lung transplant recipients have been attributed to infection from Ureaplasma parvum or U urealyticum Herein, we report a 12-year-old girl with acute myeloid leukemia and neutropenic fever who developed acute encephalopathy. Laboratory testing revealed severe hyperammonemia (blood ammonia level >1609 μmol/L) with normal liver function studies. U parvum was detected in blood, urine, and respiratory specimens by polymerase chain reaction testing. After antibiotic therapy directed against U parvum, blood ammonia levels normalized, the infection was eradicated, and the patient recovered. We propose that clinicians should test for invasive infection from Ureaplasma species in immunocompromised children with unexplained hyperammonemia.
Copyright © 2019 by the American Academy of Pediatrics.

Entities:  

Year:  2019        PMID: 31324704     DOI: 10.1542/peds.2019-0601

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Impact of Screening and Treatment of Ureaplasma species on Hyperammonemia Syndrome in Lung Transplant Recipients: A Single Center Experience.

Authors:  Scott C Roberts; Ankit Bharat; Chitaru Kurihara; Rade Tomic; Michael G Ison
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

Review 2.  [Clinical implications of the genus Mycoplasma].

Authors:  D Gómez Rufo; E García Sánchez; J E García Sánchez; M García Moro
Journal:  Rev Esp Quimioter       Date:  2021-03-18       Impact factor: 1.553

3.  A novel cause of emergent hyperammonemia: Cryptococcal fungemia and meningitis.

Authors:  William B Hannah; Gregory Nizialek; Katherine J Dempsey; Keith B Armitage; Shawn E McCandless; Laura L Konczal
Journal:  Mol Genet Metab Rep       Date:  2021-11-25

4.  Case Report: Hyperammonemic Encephalopathy Linked to Ureaplasma spp. and/or Mycoplasma hominis Systemic Infection in Patients Treated for Leukemia, an Emergency Not to Be Missed.

Authors:  Manon Delafoy; Juliette Goutines; Aude-Marie Fourmont; André Birgy; Maryline Chomton; Michaël Levy; Jérôme Naudin; Lara Zafrani; Lou Le Mouel; Karima Yakouben; Aurélie Cointe; Marion Caseris; Matthieu Lafaurie; Stéphane Bonacorsi; Françoise Mechinaud; Sabine Pereyre; Nicolas Boissel; André Baruchel
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

5.  Case Report: About a Case of Hyperammonemia Syndrome Following Lung Transplantation: Could Metagenomic Next-Generation Sequencing Improve the Clinical Management?

Authors:  Charlotte Michel; Michela Raimo; Vladimir Lazarevic; Nadia Gaïa; Nina Leduc; Christiane Knoop; Marie Hallin; Olivier Vandenberg; Jacques Schrenzel; David Grimaldi; Maya Hites
Journal:  Front Med (Lausanne)       Date:  2021-07-06

Review 6.  Hyperammonemia Post Lung Transplantation: A Review.

Authors:  Robert F Leger; Matthew S Silverman; Ellen S Hauck; Ksenia D Guvakova
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2020-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.